• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[左乙拉西坦与抗癫痫药物治疗史的相关性。成人部分性癫痫的临床经验]

[The efficacy of lacosamide in relation to antiepileptic drug history. Clinical experiences in adult partial epilepsy].

作者信息

Szűcs Anna, Horváth András, Kamondi Anita

出版信息

Ideggyogy Sz. 2015 Jan 30;68(1-2):23-9.

PMID:25842913
Abstract

OBJECTIVE

A retrospective study in adult partial epilepsy on the efficacy of lacosamide in relation to previous antiepileptic drug experiences.

METHOD

We analysed 3-65 months' data on epilepsy-care of 43 pharmacoresistant partial epilepsy patients treated with lacosamide. Further analysis of antiepileptic drug history was carried out in strictly selected subgroups of patients with good and poor therapeutic response to lacosamide (10 and 9 patients, respectively) for 2-10 years long retrospective follow up.

PATIENTS

Adult patients with partial-onset seizures had been treated previously with three or more lifetime antiepileptic drugs without permanent success.

RESULTS

Six patients (14%) were seizure free, eleven patients (25%) have experienced important improvement (their seizure-frequency decreased by at least 50%) for more than 12 months. Fourteen patients (32%) improved for less than 6 months and then have relapsed; and add-on lacosamide proved ineffective in 12 patients (28%). Those selected 10 patients successfully treated with lacosamide (seizure free for at least six months) favourably responded to carbamazepine or oxcarbazepine earlier and levetiracetam was ineffective or even caused worsening. The selected lacosamide-unresponsive nine patients responded unfavourably to carbamazepine or oxcarbazepine earlier. Fifteen patients (35%) suffered side effects as dizziness or sleepiness, in 11 of them lacosamide was combined with a "traditional" sodium-channal blocker antiepileptic drug.

CONCLUSION

Lacosamide is an effective add-on antiepileptic drug in difficult-to treat adult partial epilepsy patients. Our data suggest that good lacosamide response may be expected in those patients who reacted favourably to "traditional" sodium-channel blocker carbamazepine or oxcarbazepine earlier.

摘要

目的

对成年部分性癫痫患者进行一项回顾性研究,探讨拉科酰胺相对于既往抗癫痫药物治疗经历的疗效。

方法

我们分析了43例接受拉科酰胺治疗的药物难治性部分性癫痫患者3至65个月的癫痫治疗数据。对拉科酰胺治疗反应良好和不佳的患者(分别为10例和9例)进行严格筛选的亚组分析,进行为期2至10年的回顾性随访,并进一步分析抗癫痫药物治疗史。

患者

成年部分性发作癫痫患者此前曾接受过三种或更多种终身抗癫痫药物治疗,但未取得永久性成功。

结果

6例患者(14%)无癫痫发作,11例患者(25%)有显著改善(癫痫发作频率至少降低50%)超过12个月。14例患者(32%)改善不足6个月后复发;12例患者(28%)加用拉科酰胺无效。那10例成功接受拉科酰胺治疗(无癫痫发作至少6个月)的患者早期对卡马西平或奥卡西平反应良好,而左乙拉西坦无效甚至导致病情恶化。那9例对拉科酰胺无反应的患者早期对卡马西平或奥卡西平反应不佳。15例患者(35%)出现头晕或嗜睡等副作用,其中11例患者拉科酰胺与一种“传统”钠通道阻滞剂抗癫痫药物联用。

结论

拉科酰胺是治疗难治性成年部分性癫痫患者的一种有效附加抗癫痫药物。我们的数据表明,那些早期对“传统”钠通道阻滞剂卡马西平或奥卡西平反应良好的患者可能对拉科酰胺反应良好。

相似文献

1
[The efficacy of lacosamide in relation to antiepileptic drug history. Clinical experiences in adult partial epilepsy].[左乙拉西坦与抗癫痫药物治疗史的相关性。成人部分性癫痫的临床经验]
Ideggyogy Sz. 2015 Jan 30;68(1-2):23-9.
2
[The experience treatment of adjunctive lacosamide for patients with drug-resistance partial epilepsy].[拉考酰胺辅助治疗耐药性部分性癫痫患者的经验性治疗]
Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(9):23-8.
3
Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.作为附加疗法使用拉科酰胺治疗脑肿瘤相关性癫痫患者的生活质量、情绪及癫痫控制情况:一项设有历史对照组的前瞻性探索性研究
Epilepsy Behav. 2017 Aug;73:83-89. doi: 10.1016/j.yebeh.2017.05.031. Epub 2017 Jun 14.
4
A pooled analysis of lacosamide clinical trial data grouped by mechanism of action of concomitant antiepileptic drugs.拉科酰胺临床试验数据的汇总分析按伴随抗癫痫药物作用机制分组。
CNS Drugs. 2010 Dec;24(12):1055-68. doi: 10.2165/11587550-000000000-00000.
5
A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study.一项在日常临床实践中评估拉考酰胺添加到单药治疗对部分性发作癫痫患者有效性和安全性的非干预性研究:VITOBA研究。
Epilepsia. 2015 Dec;56(12):1921-30. doi: 10.1111/epi.13224. Epub 2015 Nov 3.
6
Lacosamide monotherapy for partial onset seizures.拉科酰胺单药治疗部分性发作癫痫。
Seizure. 2015 Apr;27:71-4. doi: 10.1016/j.seizure.2015.03.003. Epub 2015 Mar 14.
7
Efficacy and tolerability of lacosamide as an adjunctive therapy in children with refractory partial epilepsy.拉科酰胺作为难治性部分性癫痫儿童辅助治疗的疗效和耐受性
Pediatr Neurol. 2014 Oct;51(4):509-14. doi: 10.1016/j.pediatrneurol.2014.07.004. Epub 2014 Jul 16.
8
Early add-on lacosamide in a real-life setting: results of the REALLY study.现实环境中早期加用拉科酰胺:REALLY研究结果
Clin Drug Investig. 2015 Feb;35(2):121-31. doi: 10.1007/s40261-014-0255-5.
9
Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials.拉科酰胺作为成人部分性发作辅助治疗的安全性和耐受性:来自三项随机、双盲、安慰剂对照临床试验的汇总数据分析
Epilepsy Behav. 2015 Nov;52(Pt A):119-27. doi: 10.1016/j.yebeh.2015.09.006. Epub 2015 Sep 27.
10
Experience with lacosamide in a series of children with drug-resistant focal epilepsy.拉考沙胺治疗耐药性局灶性癫痫儿童系列病例的经验。
Pediatr Neurol. 2011 Jun;44(6):414-9. doi: 10.1016/j.pediatrneurol.2010.12.003.